|2021||1 month||3 months||1 year||3 years||5 years|
|MANSARTIS AMERIQUE ISR||27.48%||2.55%||10.85%||27.48%||119.96%||125.13%|
|SP 500 NR EUR||38.85%||4.79%||13.39%||38.85%||99.43%||111.44%|
|MANSARTIS AMERIQUE ISR||359.72€|
|Costco Wholesale||4.73 %|
|Alphabet A||3.95 %|
|Linde Plc||3.33 %|
|Abbott Laboratories||3.03 %|
|UNITED STATES||98.34 %|
|Large capitalisations : 99.98 %||> 10 Billions|
To lower risk
To higher risk
Liquidity risk: in the event that trading volumes on the financial markets are low, the manager may not be able to sell the securities quickly under satisfactory conditions, which has a more or less significant impact on the purchase and sale price and in certain circumstances the overall liquidity of the fund.
Credit risk: this is the risk of deterioration in the credit quality of a public or private issuer or of default by the latter. In this case, the value of the debt securities in which the fund is invested may fall, leading to a fall in the net asset value of the fund.
Counterparty risk: there is a risk that the counterparty may default on forward exchange contracts.
This page is strictly for informational purposes and should not be considered a bid or offer, nor should it be interpreted as investment advice. Past performances presented herein are based on figures from past years, and cannot be considered as predictive of future performance, nor constitute a guarantee for current or future performance.
By continuing to browse this website, you accept cookies to be saved on your computer. Those cookies are used to establish visits statistics only and to improve this website’s contents. You may block cookies by configuring your browser.